VistaGen Therapeutics


VistaGen Therapeutics (NASDAQ: VTGN) is a clinical-stage biopharmaceutical company developing new generation medicines for multiple CNS diseases and disorders with high unmet need.


Org chart

Shawn K. Singh
CEO & Director
Collapse
Reid Adler
Chief Legal Officer
Trisha Fitzmaurice
SVP, Human Resources
Joshua Prince
VP, Strategic Insights & Analytics
Louis Monti
VP, Translational Medicine
Allen Cato III
SVP, Development Operations

Board & advisors



Offices